Position in IMRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,661,018
+$21,198 QoQ
Shares Held
1,936,076
+5.8% QoQ
Ownership
2.99%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 111 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. IMRX ranks #119 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in IMRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,661,018 | 1,936,076 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,639,820 | 1,829,188 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,120,243 | 1,993,958 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,591,474 | 1,798,782 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,001,693 | 659,009 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,687,672 | 767,124 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,017,216 | 810,127 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,099,998 | 859,374 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,630,668 | 910,266 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,829,034 | 3,378,100 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $27,135,912 | 3,533,322 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $36,308,753 | 3,580,745 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $33,580,753 | 3,458,368 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $17,554,866 | 3,619,560 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $52,461,205 | 3,663,492 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,412,704 | 4,142,829 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,068,610 | 3,565,473 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $51,558,125 | 3,188,505 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $82,677,363 | 3,114,025 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||